comparemela.com

Latest Breaking News On - Novo - Page 5 : comparemela.com

Novo Nordisk s obesity drug Wegovy cuts risk of death by 18 per cent, trial data shows

Novo Nordisk’s weight-loss drug Wegovy cut the risk of death by 18 per cent in a trial that the Danish pharmaceutical company hopes will convince more health.

Small Business Tech Roundup: Using ChatGPT For Accounting? You May Want To Think Again

Also this week: Google introduces new tools for the holiday season and new AI tech can make grant writing easier.

Demand for weight-loss drugs fuels global rise in counterfeits

Novo Nordisk acquires blood pressure drug for $1 3B

COPENHAGEN: Danish drugmaker Novo Nordisk, which specialises in anti-diabetic and anti-obesity treatments, announced on Monday it is acquiring hypertension drug ocedurenone for $1.3 billion

Wegovy: Novo Nordisk India head eyes 2026 launch for obesity drug Wegovy, warns against copycats

Novo Nordisk plans to bring its weight-loss drug, Wegovy, to India in 2026. The company aims to secure regulatory approvals and ensure sufficient supply before entering the Indian market, where obesity rates are high. Counterfeit versions of Wegovy are already being sold online, but Novo Nordisk urges patients not to buy them due to safety concerns.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.